In contrast, a smaller fraction of H3K18ac (46.7%) and H3K27ac (46.3%) sites showed overlap with p300, further supporting the specific dependency of H2BNTac on p300 binding and enzymatic activity in prostate cancer cells (Figures 1E & S1C). Here, EP300 is linked to prostate carcinoma.